Understanding and Treatment for Glioma with Molecular Aspect

Zhong-ping CHEN
DOI: https://doi.org/10.3969/j.issn.1004-0242.2006.03.001
2006-01-01
Abstract:Glioma is the most common primary tumor in central nervous system(CNS)with poor prognosis.It is not uncommon that patient with same pathological profile,but the prognosis is quite different.The reasons might not be only the patient who received different treatment,but the heterogeneity of the tumor itself is also important.Currently,diagnosis and treatment for glioma have been advanced into molecular era.Molecular imaging has been introduced into neuro-oncology,so that functional imaging information now is available.Molecular neuro-pathology should become essential for diagnosis of glioma so that individualized therapy become possible.While treatment for glioma have also progressed from conventional surgery,radiation and chemotherapy to targeted molecular therapy.We can foresee that when the detailed molecular etiology has been understood,finally cured glioma should not be impossible.
What problem does this paper attempt to address?